Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis.

Chen, Xi; Zhao, Mingye; Tian, Lei

Chen, Xi; Zhao, Mingye; Tian, Lei.

Afiliación

Chen X; Department of Pharmacoeconomics, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Zhao M; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, China.
Tian L; Department of Pharmacoeconomics, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.

Front Pharmacol ; 14: 1119906, 2023.

Article en En | MEDLINE | ID: mdl-37021058

Palabras clave

cost-effectiveness; fractional polynomial; network meta-analysis; non-squamous non-small cell lung cancer; partitioned survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspecto: Patient_preference Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google